- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Caplin Point Laboratories Ltd (CAPL)
Caplin Point Laboratories Ltd stock price live, this page displays NSE CAPL stock exchange data. View the CAPL premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Caplin Point Laboratories Ltd real time stock price chart below.
What Is the Caplin Point Laboratories Ltd Stock Price Today?
The Caplin Point Laboratories Ltd stock price today is 2,754.90.
What Is the Stock Symbol for Caplin Point Laboratories Ltd?
The stock symbol for Caplin Point Laboratories Ltd is "CAPL."
What Stock Exchange Does Caplin Point Laboratories Ltd Trade On?
Caplin Point Laboratories Ltd is listed and trades on the NSE stock exchange.
Is Caplin Point Laboratories Ltd a Good Stock to Buy?
Determining whether Caplin Point Laboratories Ltd, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CAPL quote. (ISIN: INE475E01026)
What Is the Caplin Point Laboratories Ltd Stock Price Today?
The Caplin Point Laboratories Ltd stock price today is 2,754.90.
What Is the Stock Symbol for Caplin Point Laboratories Ltd?
The stock symbol for Caplin Point Laboratories Ltd is "CAPL."
What Stock Exchange Does Caplin Point Laboratories Ltd Trade On?
Caplin Point Laboratories Ltd is listed and trades on the NSE stock exchange.
Is Caplin Point Laboratories Ltd a Good Stock to Buy?
Determining whether Caplin Point Laboratories Ltd, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CAPL quote. (ISIN: INE475E01026)
2,754.90
-40.50(-1.45%)
Closed·
Fair Value
An estimate of a Caplin Point Laboratories Ltd's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2,716.00
2,790.10
52 wk Range
1,500.30
2,877.30
CAPL is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Caplin Point Laboratories Ltd's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2,716.002,790.10
52 wk Range
1,500.302,877.30
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.29%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.29%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
CAPL Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Caplin Point Laboratories Ltd's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a high P/E ratio relative to near-term earnings growth
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Sell
Moving Averages
Buy
Caplin Point Laboratories Ltd Earnings Call Summary for Q1/2027
- Caplin Point reported 20% revenue growth in Q1 2026 with EBITDA margin rising to 38.4%; shares fell 6.3% to $2,464 despite strong results.
- U.S. subsidiary Caplin Steriles tripled revenue to INR 43.1 crores; gross margin held at 59.8%, above the 55% target with zero external debt.
- Management cited capacity, not demand, as main constraint; company booked until February 2026 with plants near full utilization.
- Plans to expand sterile injectable lines from 7 to 17; Line 7 expected in 6-7 months, five more within a year to address capacity bottleneck.
- Cash reserves surged to INR 1,500 crores from INR 231 crores; company targeting 60% gross margin with disciplined operating expense management.
Last Updated: 12/08/2026, 13:12
Read Full TranscriptEarnings
Latest Release
Aug 12, 2026
EPS / Forecast
23.30 / --
Revenue / Forecast
6.1B / 5.21B
Compare CAPL to Peers and Sector
Metrics to compare | CAPL | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCAPLPeersSector | |
|---|---|---|---|---|
P/E Ratio | 31.5x | 38.1x | −0.4x | |
PEG Ratio | 1.76 | 0.73 | 0.00 | |
Price/Book | 6.0x | 4.4x | 2.6x | |
Price / LTM Sales | 9.2x | 4.0x | 3.0x | |
Upside (Analyst Target) | 0.4% | 3.4% | 55.1% | |
Fair Value Upside | Unlock | 1.1% | 8.2% | Unlock |
Caplin Point Laboratories Limited, together with its subsidiaries, engages in the development, production, marketing, and export of generic formulations and branded products in India. The company provides tablets, capsules, injections, ophthalmic, liquid orals, softgel, capsules, ointments, creams and gels, powder for injections, suppositories, ovules, pre-mix bag, inhalers, and sprays and IV infusion. It also provides dry and syrups, lyophilized vials, prefilled syringes, emulsion injection, ophthalmic droppers, sachets, liquid injectables, topicals, pre-filled syringes, and pre-mix bags. Caplin Point Laboratories Limited was incorporated in 1990 and is headquartered in Chennai, India.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Caplin Point Laboratories Ltd (CAPL) Stock Price Today?
The Caplin Point Laboratories Ltd stock price today is 2,754.90 INR.
What Stock Exchange Does Caplin Point Laboratories Ltd Trade On?
Caplin Point Laboratories Ltd is listed and trades on the India National Stock Exchange.
What Is the Stock Symbol for Caplin Point Laboratories Ltd?
The stock symbol for Caplin Point Laboratories Ltd is "CAPL."
What Is the Caplin Point Laboratories Ltd Market Cap?
As of today, Caplin Point Laboratories Ltd market cap is 209.39B INR.
What Is Caplin Point Laboratories Ltd's Earnings Per Share (TTM)?
The Caplin Point Laboratories Ltd EPS (TTM) is 87.29.
When Is the Next Caplin Point Laboratories Ltd Earnings Date?
Caplin Point Laboratories Ltd will release its next earnings report on Nov 05, 2026.
From a Technical Analysis Perspective, Is CAPL a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Caplin Point Laboratories Ltd Stock Split?
Caplin Point Laboratories Ltd has split 1 times.
How Many Employees Does Caplin Point Laboratories Ltd Have?
Caplin Point Laboratories Ltd has 4199 employees.
What is the current trading status of Caplin Point Laboratories Ltd (CAPL)?
As of Sep 13, 2026, Caplin Point Laboratories Ltd (CAPL) is trading at a price of 2,754.90 INR, with a previous close of 2,795.40 INR. The stock has fluctuated within a day range of 2,716.00 INR to 2,790.10 INR, while its 52-week range spans from 1,500.30 INR to 2,877.30 INR.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.